Cargando…

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

The current worldwide monkepox outbreak has reaffirmed the continued threat monkeypox virus (MPXV) poses to public health. JYNNEOS, a Modified Vaccinia Ankara (MVA)-based live, non-replicating vaccine, was recently approved for monkeypox prevention for adults at high risk of MPXV infection in the Un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Priyamvada, Lalita, Carson, William C., Ortega, Eddy, Navarra, Terese, Tran, Stephanie, Smith, Todd G., Pukuta, Elisabeth, Muyamuna, Elisabeth, Kabamba, Joelle, Nguete, Beatrice U., Likafi, Toutou, Kokola, Gaston, Lushima, Robert Shongo, Tamfum, Jean-Jacques Muyembe, Okitolonda, Emile W., Kaba, Didine K., Monroe, Benjamin P., McCollum, Andrea M., Petersen, Brett W., Satheshkumar, Panayampalli S., Townsend, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635871/ https://www.ncbi.nlm.nih.gov/pubmed/36344361 http://dx.doi.org/10.1016/j.vaccine.2022.10.078

Ejemplares similares

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo
por: Osadebe, Lynda, et al.
Publicado: (2017)

A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo
por: Hughes, Christine M., et al.
Publicado: (2021)

Vaccinating against monkeypox in the Democratic Republic of the Congo
por: Petersen, Brett W., et al.
Publicado: (2019)

Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo
por: Nolen, Leisha Diane, et al.
Publicado: (2016)

Sounding the alarm: Defining thresholds to trigger a public health response to monkeypox
por: Guagliardo, Sarah Anne J., et al.
Publicado: (2018)

Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research
por: Reynolds, Mary G., et al.
Publicado: (2017)

Herpes Infections in Suspected Cases of Yellow Fever in the Democratic Republic of the Congo
por: Makiala-Mandanda, Sheila, et al.
Publicado: (2021)

Use of Mpox Multiplex Serology in the Identification of Cases and Outbreak Investigations in the Democratic Republic of the Congo (DRC)
por: Kinganda-Lusamaki, Eddy, et al.
Publicado: (2023)

Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash–fever illnesses in the Democratic Republic of the Congo
por: Wawina, Tony Bokalanga, et al.
Publicado: (2017)

Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022
por: Rosenberg, Eli S., et al.
Publicado: (2023)

Antiviral activities of two nucleos(t)ide analogs against vaccinia and mpox viruses in primary human fibroblasts
por: Dsouza, Lara, et al.
Publicado: (2023)

Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts
por: Dsouza, Lara, et al.
Publicado: (2023)

JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study
por: Lee, Jaeeun, et al.
Publicado: (2023)

New methylene blue derivatives suggest novel anti-orthopoxviral strategies
por: Priyamvada, Lalita, et al.
Publicado: (2021)

Measles Virus Strain Diversity, Nigeria and Democratic Republic of the Congo
por: Kremer, Jacques R., et al.
Publicado: (2010)

Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity
por: Priyamvada, Lalita, et al.
Publicado: (2020)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

Asymptomatic Orthopoxvirus Circulation in Humans in the Wake of a Monkeypox Outbreak among Chimpanzees in Cameroon
por: Guagliardo, Sarah Anne J., et al.
Publicado: (2020)

Detection of Human Monkeypox in the Republic of the Congo Following Intensive Community Education
por: Reynolds, Mary G., et al.
Publicado: (2013)

Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines
por: Meo, Sultan Ayoub, et al.
Publicado: (2022)

Epidemiologic and Ecologic Investigations of Monkeypox, Likouala Department, Republic of the Congo, 2017
por: Doshi, Reena H., et al.
Publicado: (2019)

Evaluation of the influenza sentinel surveillance system in the Democratic Republic of Congo, 2012–2015
por: Babakazo, Pélagie, et al.
Publicado: (2019)

Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
por: Kriss, Jennifer L., et al.
Publicado: (2022)

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022)

JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox — United States, May 22, 2022–January 31, 2023
por: Owens, Lauren E., et al.
Publicado: (2023)

The national and provincial burden of medically attended influenza‐associated influenza‐like illness and severe acute respiratory illness in the Democratic Republic of Congo, 2013‐2015
por: Babakazo, Pélagie, et al.
Publicado: (2018)

Suppression of Poxvirus Replication by Resveratrol
por: Cao, Shuai, et al.
Publicado: (2017)

Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil
por: Barbosa Costa, Galileu, et al.
Publicado: (2021)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Frameworks for Preventing, Detecting, and Controlling Zoonotic Diseases
por: Shiferaw, Miriam L., et al.
Publicado: (2017)

Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine — California, May 2022–May 2023
por: Schildhauer, Samuel, et al.
Publicado: (2023)

Design and Optimization of a Monkeypox virus Specific Serological Assay
por: Taha, Taha Y., et al.
Publicado: (2023)

Leptospirosis as a cause of fever associated with jaundice in the Democratic Republic of the Congo
por: Mukadi Kakoni, Patrick, et al.
Publicado: (2021)

The 90 MVA transformer
Publicado: (1974)

Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022
por: Minhaj, Faisal S., et al.
Publicado: (2023)

Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015
por: Kavunga-Membo, Hugo, et al.
Publicado: (2018)

Possible Undetected Mpox Infection Among Persons Accessing Homeless Services and Staying in Encampments — San Francisco, California, October–November 2022
por: Waddell, Caroline J., et al.
Publicado: (2023)

Antecedent causes of a measles resurgence in the Democratic Republic of the Congo
por: Scobie, Heather Melissa, et al.
Publicado: (2015)

Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival — Louisiana, August 9–September 5, 2022
por: Soelaeman, Rieza H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sa2fq41ijslc3ir88pb9vshga2